SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (2928)1/25/2011 2:06:29 AM
From: Ian@SI  Read Replies (1) | Respond to of 3158
 
I would agree. $0.5B for a failure sounds really expensive. Nevertheless $1.0B for a successful cancer vaccine would turn out to be a steal. I know nothing about the company nor the science behind their "vaccine" attempt but very promising "shots" have failed after PhIII and the only limited cancer success I can think of is Provenge - far from a $B purchase in my mind.

regards,
Ian